PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $790 | +54.6% | 45,587 | +137.4% | 0.07% | +33.3% |
Q1 2023 | $511 | +30.4% | 19,206 | -5.2% | 0.05% | +4.1% |
Q4 2022 | $392 | -99.9% | 20,259 | -8.9% | 0.05% | -21.0% |
Q3 2022 | $464,000 | -20.7% | 22,235 | -69.6% | 0.06% | -29.5% |
Q2 2022 | $585,000 | +22.4% | 73,053 | +7.1% | 0.09% | +37.5% |
Q1 2022 | $478,000 | -39.6% | 68,236 | +16.5% | 0.06% | -35.4% |
Q4 2021 | $791,000 | +81.0% | 58,593 | +126.5% | 0.10% | +120.0% |
Q3 2021 | $437,000 | – | 25,867 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |